← ImmunityBio, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $8.1m | $23.9m | $16.8m | $15.5m | $11.4m | $181.1m | $104.6m | $265.5m | $143.4m | $88.3m | |
| Prepaid Expense and Other Assets, Current | $5.1m | $4.2m | $13.8m | $4.1m | $9.3m | $15.9m | $31.5m | $25.6m | $23.9m | $28.5m | |
| Inventory, Net | — | — | — | — | — | — | — | $0 | $8.3m | $910k | |
| Assets, Current | $205.1m | $132.5m | $88.8m | $55.8m | $75.5m | $334.3m | $140.6m | $294.1m | $184.6m | $314.9m | |
| Property, Plant and Equipment, Net | $18.9m | $76.7m | $76.9m | $60.5m | $53.9m | $82.9m | $143.7m | $146.1m | $137.1m | $114.3m | |
| Goodwill | — | — | — | — | — | — | — | — | $910k | $910k | |
| Intangible Assets, Net (Excluding Goodwill) | $5.1m | $2.8m | $565k | $0 | — | $1.4m | $20.0m | $17.1m | $15.9m | $14.0m | |
| Operating Lease, Right-of-Use Asset | — | — | $0 | $11.7m | $13.5m | $36.3m | $45.8m | $36.5m | $33.4m | $33.0m | |
| Other Assets, Noncurrent | $788k | $330k | $1.5m | $4.4m | $1.1m | $6.8m | $4.9m | $2.9m | $4.8m | — | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | — | — | — | — | — | $2.4m | $42.6m | |
| Accrued Liabilities, Current | $5.9m | $11.3m | $21.1m | $5.3m | $8.3m | $51.4m | $41.8m | $42.7m | $40.6m | $46.8m | |
| Assets | $317.5m | $250.4m | $181.9m | $143.1m | $151.9m | $468.9m | $362.4m | $504.5m | $382.9m | $501.9m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | $0 | $3.2m | $5.5m | $3.0m | $2.6m | $5.2m | $7.5m | $7.5m | |
| Accounts Payable, Current | $4.0m | $5.9m | $2.8m | $1.7m | $4.1m | $11.4m | $21.0m | — | — | — | |
| Operating Lease, Liability, Noncurrent | — | — | — | $10.9m | $9.8m | $37.1m | $48.0m | $39.9m | $34.8m | $33.4m | |
| Deferred Revenue, Noncurrent | $187k | $166k | — | — | — | — | — | — | — | — | |
| Liabilities, Current | $12.6m | $20.9m | $27.3m | $11.6m | $24.7m | $369.0m | $500.9m | $58.3m | $54.9m | $61.8m | |
| Deferred Income Tax Liabilities, Net | — | — | — | — | — | $162k | — | — | — | — | |
| Other Liabilities, Noncurrent | $240k | $89k | $0 | — | — | $249k | $457k | $1.1m | $639k | $424k | |
| Deferred Tax Liabilities, Net | $996k | $498k | $0 | $0 | $0 | $162k | $158k | $148k | $139k | $0 | |
| Liabilities | $24.1m | $31.6m | $35.9m | $22.4m | $34.5m | $712.8m | $812.2m | $1.1b | $871.1m | $1.0b | |
| Commitments and Contingencies | — | — | $0 | $0 | $0 | — | — | — | — | — | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $8k | $8k | $8k | $10k | $11k | $40k | $42k | $67k | $85k | $101k | |
| Retained Earnings (Accumulated Deficit) | ($387.1m) | ($498.7m) | ($595.0m) | ($662.2m) | ($754.6m) | ($2.0b) | ($2.4b) | ($3.0b) | ($3.4b) | ($3.7b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($284k) | ($381k) | ($267k) | ($105k) | ($122k) | $4k | $183k | $10k | $1.2m | $29.0m | |
| Additional Paid in Capital, Common Stock | $680.8m | $717.9m | $741.2m | $783.0m | $872.1m | $1.7b | $1.9b | $2.4b | $2.9b | $3.2b | |
| Stockholders' Equity Attributable to Parent | $293.4m | $218.8m | $146.0m | $120.7m | $117.4m | ($242.2m) | ($447.3m) | ($587.0m) | ($489.1m) | ($500.5m) | |
| Stockholders' Equity Attributable to Noncontrolling Interest | — | — | — | — | — | ($1.7m) | ($2.5m) | $1.1m | $969k | $895k | |
| Liabilities and Equity | $317.5m | $250.4m | $181.9m | $143.1m | $151.9m | $468.9m | $362.4m | $504.5m | $382.9m | $501.9m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.